Wang, Y., Jia, R., Si, H., Ma, Y., Fan, M., Zhang, N., . . . Dai, G. Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer. BMC.
Chicago Style (17th ed.) CitationWang, Yanrong, et al. Efficacy and Safety of Sintilimab Plus Bevacizumab and CAPOX as First-line Treatment for Patients with RAS-mutant, Microsatellite Stable, Metastatic Colorectal Cancer. BMC.
MLA (9th ed.) CitationWang, Yanrong, et al. Efficacy and Safety of Sintilimab Plus Bevacizumab and CAPOX as First-line Treatment for Patients with RAS-mutant, Microsatellite Stable, Metastatic Colorectal Cancer. BMC.
Warning: These citations may not always be 100% accurate.